Royal Biologics Withdraws From Wound Care Stakeholders Alliance
04 Apr 2025 //
ACCESSWIRE
Royal Biologics Partners With Coldplasmatech For Collaboration
25 Feb 2025 //
ACCESSWIRE
Royal Wound-X Begins Trials After IRB Approval For Pivotal Products
11 Sep 2024 //
ACCESSWIRE
Royal Biologics Announces U.S. Commercial Launch of BIOINCYTEâ„¢ PRFM
14 Feb 2023 //
GLOBENEWSWIRE